Keywords: Daiichi Sankyo, Fiancial results 2009, Biota, CS-8958, Influenza

Daiichi Sankyo ups profit forecast by 13% on expected rupee gain related to Ranbaxy; files flu drug in Japan

Article | 01 February 2010

Print This

Japanese drug major Daiichi Sankyo has raised its full-year net income forecast for the fiscal year to March 31 by 13% to 45 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in